Foscarnet eyedrops for the treatment of refractory herpetic keratitis-Reference-Cited by-同舟云学术

Foscarnet eyedrops for the treatment of refractory herpetic keratitis

Published:2023-07-20 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Awh Caroline C.¹,Knapp Austen N.¹,Goshe Jeffrey M.¹,See Craig W.¹,Lowder Careen Y.¹

Affiliation:

1. Cole Eye Institute Cleveland Clinic

Abstract

Abstract Purpose The purpose of this case series is to describe the clinical course of patients receiving foscarnet eyedrops for the treatment of refractory herpetic keratitis. Observations: Six patients diagnosed with herpetic keratitis were treated with foscarnet 24 mg/mL (2.4%) eyedrops with resulting improvement in keratitis. Conclusion Topical foscarnet may be a safe and effective treatment for herpetic keratitis in conjunction with, or as an alternative to, conventional antiviral therapy. This is an off-label use of foscarnet.

Publisher

Research Square Platform LLC

Reference14 articles.

1. White ML, Chodosh J, Center for Quality Eye Care and American Academy of Ophthalmology Website (2014) Herpes Simplex Virus Keratitis: A Treatment Guideline. Hoskins ; Available at: https://www.aao.org/clinical-statement/herpes-simplex-virus-keratitis-treatment-guideline. Accessed January 16, 2022

2. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis;Velzen M;J Infect Dis

3. Herpes simplex virus epidemiology and ocular importance;Liesegang TJ;Cornea,2001

4. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals;Velzen M;J Infect Dis 2012 May

5. Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management;Piret J;Curr Opin Infect Dis